BNTX - Could Pfizer Be a Millionaire-Maker Stock?
Pfizer (NYSE: PFE) was all over the headlines this week after Monday's promising results regarding the coronavirus vaccines it is co-developing along with BioNTech (NASDAQ: BNTX). On top of that, the U.S. government said it will pay the companies $1.95 billion to secure as many as 600 million doses of any successful vaccines they produce, provided they are cleared by the U.S. Food and Drug Administration (FDA).
Not surprisingly, that one-two punch has given the pharmaceutical company's shares a boost. As of market close Friday, Pfizer stock was $37.66 per share, almost 6% above what it was when it closed last Friday.
Image source: Getty Images.